What is being reviewed?

30 of 30 brand reviews

Clinical care

A service can describe assessment and prescribing. Its public page may leave the exact medicine unidentified.

Online care

CoreAge Rx

Published oral micronized progesterone offer; the final compounded preparation, ingredients and dispensing pharmacy require confirmation.

A close reading of the advertised capsule, its compounding statement, starting price, and the product details still needed.

Online care

Alloy

Online menopause prescribing with a progesterone pill listing; approval language is attributed to the provider, without verification of a selected manufacturer or dispensed formulation.

Bioidentical, FDA-approved and pill are different claims; Alloy’s product page does not provide the complete dispensing identity that would connect them.

Online care

Midi Health

Online menopause care with a compounded oral micronized progesterone listing; product availability excludes Arizona and selected ingredients, suitability and complete costs require individual confirmation.

Midi names an oral compounded product and its inactive ingredients; the description is more specific than a hormone category but still has clear verification limits.

Online care

Evernow

Online menopause care offering progesterone when prescribed; the reviewed treatment page does not confirm a particular brand, oral capsule, manufacturer or complete ingredient label.

Evernow verifies access to progesterone care, but its public treatment description does not settle a capsule brand, complete formulation or regulatory record.

Online care

Winona

Online menopause service with capsule and compounded combination-cream offers; ingredient descriptions and approval claims are provider records, not verified patient supplies.

Winona’s capsule and combination cream provide different ingredient records, while its FAQ uses conflicting language about approval and compounding.

Online care

Gennev

Virtual menopause physician and dietitian service; relevant prescribing is documented, but no exact progesterone route, manufacturer or capsule formulary is established in the reviewed pages.

Gennev’s consultation and pharmacy pathway are documented, while an oral product, particle-size description and complete ingredient record remain unconfirmed.

Online care

MyMenopauseRx

Online menopause care naming approved estradiol and progesterone treatments; the public list does not confirm each hormone in every route or authenticate a selected manufacturer and formulation.

The provider names estradiol and progesterone alongside several delivery forms, but that collective description does not assign every form to each hormone.

Online care

Pandia Health

Online menopause care and pharmacy services with progesterone and Prometrium capsule entries; selected stock, product identity, clinical eligibility and complete billing remain unverified.

Pandia names Prometrium and progesterone capsules, but a catalog position does not verify stock, a selected manufacturer or the terms of an individual order.

Online care

Stella

US virtual menopause clinic with progesterone capsules in example plans; the exact formulation, manufacturer and selected treatment remain unconfirmed, with US access and visit terms retained.

Stella’s US clinic illustrates care with progesterone capsules, but the example does not identify a manufacturer, complete formula or product-specific approval record.

Online care

Wisp

Online menopause consultation listing micronized progesterone and other oral options; prescribing is conditional and exact supply, pharmacy price and personal eligibility remain unverified.

Wisp lists micronized progesterone and Provera within its menopause options; their neighboring placement does not make their active ingredients or labels interchangeable.

Online care

Thrivelab

US menopause consultation service describing compounded hormone prescriptions; confirm state access and the exact preparation.

Thrivelab identifies a compounded-care pathway. Its pharmacy wording and historical medicine table leave different questions about the actual progesterone preparation.

Online care

Defy Medical

US hormone consultation service; a broad hormone and route menu does not verify a particular progesterone product.

Defy’s menopause and hormone pages establish a care service. Its route menu and average spending figures do not identify a particular micronized progesterone prescription.

Clinic network

BodyLogicMD

US menopause-care network with membership and member-priced services; the exact prescribing practice and progesterone preparation remain to be confirmed.

BodyLogicMD describes bioidentical hormone care and a membership. Neither a clinician directory nor a hormone panel identifies the progesterone that a patient would receive.

Clinic network

Renew Youth

US menopause-care service; published progesterone discussion does not identify an exact oral or topical preparation.

Renew’s progesterone discussion uses reassuring origin and benefit language. Its care offer, route discussion and introductory charge need separate interpretation.

Online care

Hone Health

US menopause-care service listing a compounded oral progesterone capsule; exact formulation, eligibility and selected charges require confirmation.

Hone names a compounded oral capsule and an estimated medicine charge. That helps identify the offer while leaving formulation, evidence and complete membership costs distinct.

Online care

Lifeforce

US clinician-led menopause offer with a Micronized Progesterone page; route, exact preparation and conflicting plan descriptions remain unresolved.

Lifeforce names micronized progesterone, but its product details and plan descriptions leave important gaps, including an ambiguous ingredient warning and conflicting prices.

Online care

Fountain

US hormone-care service advertising a Hormone Therapy Kit; exact progesterone route and preparation are unconfirmed.

Fountain names progesterone within a care package. Its kit wording, week-based billing and pharmacy terms do not establish a particular micronized medicine.

Clinic network

Alpha Hormones

Pasadena and published CA, TX and FL care access; provider describes an FDA-approved oral micronized option without naming the supplied product.

Alpha explicitly describes FDA-approved oral micronized progesterone. The category is useful, but the exact manufacturer, ingredients and selected membership terms remain separate questions.

Clinic network

Newson Clinic

UK menopause consultations in person or by video; exact progesterone product and individual UK access or prescribing arrangements are unconfirmed.

Newson names progesterone within UK consultations. An independently labeled UK capsule helps explain terminology, but does not prove what this clinic prescribes or supplies.

Health system

Duke Health

Duke regional North Carolina menopause care; exact micronized preparation, regulatory product record, pharmacy and total costs unconfirmed.

Duke names progesterone and regulated bioidentical hormone therapy. Those words describe its treatment discussion without identifying an approved finished product, particle specification or pharmacy supply.

Health system

Cleveland Clinic

Cleveland Clinic clinical pathways, including distinct US and London services; exact product, manufacturer, personal eligibility and charges not verified.

Cleveland’s specialized women’s health page names bioidentical therapy. Chemical identity, manufacturing, inactive ingredients and the formulation offered to a patient remain separate questions.

Health system

Mayo Clinic

Mayo Minnesota and Florida consultation programs; no named micronized product, pharmacy fulfillment or universal access established.

Mayo includes questions about bioidentical hormones in its menopause consultation remit. That invitation does not identify a brand, approve every formulation or establish a pharmacy offer.

Health system

Johns Hopkins Medicine

Referral-based menopause care with conditional Maryland/Florida telemedicine; educational terminology does not identify an oral product or establish unrestricted access.

An institutional menopause article uses bioidentical language within an alternative-therapy discussion. That wording does not define a regulated product or identify what the separate clinical service prescribes.

Health system

Mount Sinai

New York City menopause service; a May 2021 educational interview names progesterone but does not establish a current micronized preparation or dispensing offer.

A dated Mount Sinai educational interview names progesterone, while the current service information confirms menopause care. Neither supplies an exact micronized product offer.

Health system

Northwestern Medicine

Chicago menopause program lists off-label options generally; exact progesterone product, use, pharmacy, individual access and total charges remain unresolved.

Northwestern lists off-label options within its menopause program. The term needs a named drug and proposed use before it says anything precise about a progesterone decision.

Health system

UCLA Health

UCLA menopause clinical program plus dated educational approval language; exact progesterone preparation and pharmacy offer are unconfirmed, with no universal access or price claim.

UCLA’s educational article recommends an FDA-approved category but does not identify a progesterone product supplied through its menopause program. Regulatory status, chemical identity and route remain distinct.

Health system

Stanford Health Care

Stanford menopause care and conditional appointment options; progesterone is named, but exact micronized product, route assignment, pharmacy and personal eligibility are unverified.

Stanford names progesterone in a treatment explanation. The hormone identity should be preserved without assigning a particular micronized formulation or importing results from another active ingredient.

Health system

University of Utah Health

Utah regional midlife care with separate educational conventional/compounded distinction; no specific micronized product, ingredient transfer, pharmacy, total price or national access established.

Utah’s postmenopause education distinguishes conventional bioidentical medicines from compounded options. The distinction helps frame approval questions without identifying a product prescribed by its midlife service.

A medicine label

An identified product has its own record. That label cannot identify another provider’s capsule or establish your prescription.

Product brand

Prometrium

A named oral-capsule label; its ingredients and approved uses describe that product, without establishing a personal prescription or pharmacy stock.

What the current named-product label establishes, from oral capsule identity to the limits of micronization and approval language.

A dispensing service

A pharmacy listing answers a different question from a clinical consultation. Confirm the supplied product and final order terms.

Pharmacy

Cost Plus Drugs

A prescription generic-progesterone dispensing listing; the selected manufacturer, final quote and care arrangements remain order-specific.

A current catalog price can help compare dispensing costs, but it does not identify a guaranteed manufacturer or include menopause prescribing care.